Hening Lin to Neoplasms
This is a "connection" page, showing publications Hening Lin has written about Neoplasms.
Connection Strength
1.551
-
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets. Nat Rev Cancer. 2024 Apr; 24(4):240-260.
Score: 0.284
-
Interactome Analysis Identifies the Role of BZW2 in Promoting Endoplasmic Reticulum-Mitochondria Contact and Mitochondrial Metabolism. Mol Cell Proteomics. 2024 Feb; 23(2):100709.
Score: 0.281
-
A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions. Mol Cell Proteomics. 2022 08; 21(8):100268.
Score: 0.254
-
Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. Proc Natl Acad Sci U S A. 2022 03 15; 119(11):e2117013119.
Score: 0.248
-
N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections. ACS Chem Biol. 2020 07 17; 15(7):1747-1758.
Score: 0.219
-
Lessons learned from a SIRT2-selective inhibitor. Oncotarget. 2016 04 26; 7(17):22971-2.
Score: 0.165
-
IGF2BP2 promotes cancer progression by degrading the RNA transcript encoding a v-ATPase subunit. Proc Natl Acad Sci U S A. 2022 Nov 08; 119(45):e2200477119.
Score: 0.065
-
Sirtuin inhibitors as anticancer agents. Future Med Chem. 2014 May; 6(8):945-66.
Score: 0.036